Media coverage about Dynatronics Corporation (NASDAQ:DYNT) has been trending positive this week, Accern Sentiment reports. The research group ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Dynatronics Corporation earned a coverage optimism score of 0.25 on Accern’s scale. Accern also assigned news stories about the medical equipment provider an impact score of 47.231731418183 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Here are some of the news stories that may have effected Accern’s rankings:
- BRIEF-Dynatronics Corp says net sales for quarter increased 56.8 pct to $12.8 mln (DYNT) (markets.businessinsider.com)
- Dynatronics’ (DYNT) CEO Kelvyn Cullimore Jr. on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com)
- Edited Transcript of DYNT earnings conference call or presentation 14-Nov-17 1:30pm GMT (finance.yahoo.com)
- Dynatronics Announces 57% increase in Top Line Sales for Fiscal 2018 First Quarter (finance.yahoo.com)
- Dynatronics Corporation (DYNT) Issues Earnings Results (americanbankingnews.com)
A number of brokerages have commented on DYNT. Zacks Investment Research downgraded shares of Dynatronics Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. ValuEngine upgraded shares of Dynatronics Corporation from a “strong sell” rating to a “sell” rating in a report on Friday, July 28th.
Dynatronics Corporation (NASDAQ DYNT) opened at $2.60 on Wednesday. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.77 and a quick ratio of 0.80. Dynatronics Corporation has a fifty-two week low of $2.10 and a fifty-two week high of $3.75.
Dynatronics Corporation (NASDAQ:DYNT) last announced its earnings results on Tuesday, November 14th. The medical equipment provider reported $0.00 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.08. Dynatronics Corporation had a negative net margin of 5.47% and a negative return on equity of 88.57%. equities analysts expect that Dynatronics Corporation will post -0.38 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by Week Herald and is owned by of Week Herald. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://weekherald.com/2017/11/15/dynatronics-corporation-dynt-earns-daily-news-impact-rating-of-0-25.html.
About Dynatronics Corporation
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
Receive News & Ratings for Dynatronics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.